Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178035 · ClinicalTrials.gov registry record · Phase 4
Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly Individuals
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 158
- Enrollment target
NCT00178035 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 158 participants.
The verdict
NCT00178035, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 158 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of total sleep deprivation (TSD) for one night plus paroxetine versus either TSD plus placebo or paroxetine alone in inducing rapid symptom resolution of major depression in the elderly.
Interventions
- DRUG paroxetine
- BEHAVIORAL One night of Total Sleep Deprivation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 1999-12 |
| Est. Completion | 2003-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178035
The ClinicalTrials.gov registry entry for NCT00178035 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which paroxetine is the first listed.
NCT00178035 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00178035 about?
NCT00178035 is a clinical study titled "Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly Individuals". This study will determine the effectiveness of total sleep deprivation (TSD) for one night plus paroxetine versus either TSD plus placebo or paroxetine alone in inducing rapid symptom resolution of major depression in the elderly.
What is the current status of trial NCT00178035?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 158 participants. The study started on 1999-12. Estimated completion is 2003-08.
What interventions are being tested in trial NCT00178035?
The interventions under investigation include: paroxetine (DRUG), One night of Total Sleep Deprivation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00178035?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.